Zoetis (ZTS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • Thursday
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarZacks Investment Research • Wednesday
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 10/23/26
ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?Zacks Investment Research • 10/21/26
Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection TreatmentBusiness Wire • 10/20/26
A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right NowThe Motley Fool • 10/09/26
New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1Business Wire • 10/06/26
Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial ResultsBusiness Wire • 09/24/26
Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 09/18/26
Zoetis Inc. (ZTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26